Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Anticonvulsants for alcohol withdrawal.

A Polycarpou1, P Papanikolaou, J P A Ioannidis

  • 1Department of Hygiene and Epidemiology, University of Ioannina, School of Medicine, 14 Ch Zoidi Str, Ioannina, Greece, GR45444. anastpoly@yahoo.gr

The Cochrane Database of Systematic Reviews
|July 22, 2005
PubMed
Summary

Anticonvulsants may offer some benefit for alcohol withdrawal symptoms, potentially reducing seizures and side effects compared to other treatments. However, more research is needed due to trial heterogeneity.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Non-genetic risk indicators for preterm birth: An umbrella review of systematic reviews and meta-analyses.

European journal of obstetrics, gynecology, and reproductive biology·2026
Same author

Requesting conflicts of interest declarations from the European Medicines Agency: 3-year follow-up status.

Epidemiology and psychiatric sciences·2024
Same author

Hundreds of thousands of zombie randomised trials circulate among us.

Anaesthesia·2020
Same author

Dental Research Waste in Design, Analysis, and Reporting: A Scoping Review.

Journal of dental research·2020
Same author

The role of meta-analyses and umbrella reviews in assessing the harms of psychotropic medications: beyond qualitative synthesis.

Epidemiology and psychiatric sciences·2018
Same author

Overlapping network meta-analyses on the same topic: survey of published studies.

International journal of epidemiology·2017

Area of Science:

  • Pharmacology
  • Neurology
  • Addiction Medicine

Background:

  • Alcohol withdrawal syndrome (AWS) is a common and potentially severe condition following alcohol cessation in dependent individuals.
  • Anticonvulsant medications are explored as a treatment option for managing AWS symptoms.

Purpose of the Study:

  • To systematically review and evaluate the efficacy and safety of anticonvulsants in treating alcohol withdrawal symptoms.
  • To compare anticonvulsants against placebo and other pharmacological interventions for AWS.

Main Methods:

  • A comprehensive search of multiple databases (Cochrane, MEDLINE, EMBASE) was conducted for randomized controlled trials (RCTs).
  • Inclusion criteria focused on RCTs comparing anticonvulsants with placebo, other drugs, or other anticonvulsants for AWS.

Related Experiment Videos

  • Data extraction and quality assessment were performed independently by the authors.

    • Main Results:

    • Forty-eight RCTs involving 3610 participants were analyzed, revealing heterogeneity in outcomes and assessment scales.
    • Anticonvulsants showed a trend towards increased therapeutic success and seizure reduction versus placebo, but without statistical significance.
    • Compared to other drugs, anticonvulsants demonstrated a statistically significant benefit in one subgroup analysis (carbamazepine vs. benzodiazepine) for symptom reduction, with fewer reported side effects.

    Conclusions:

    • Definitive conclusions on the effectiveness and safety of anticonvulsants for AWS are limited by significant heterogeneity in study interventions and outcome measures.
    • While mortality rates were low, safety data beyond mortality remain sparse and fragmented.
    • Further high-quality, standardized research is necessary to establish the role of anticonvulsants in managing alcohol withdrawal.